Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by LordoftheMarketon Mar 21, 2018 11:18am
83 Views
Post# 27753391

This land deal will be absolutely massive for ISOL

This land deal will be absolutely massive for ISOL Remember Canopy Grasslands signed a deal to grow hemp in Sask...In addition to acquiring Green's farm operations and associated assets, equipment, genetic stock, and other property, Canopy Growth will operate approximately 300 acres of existing hemp production after completion of the Transaction, which it anticipates will be scalable to 2,200 acres for the 2018 growing season.

Isol's is 10x the size and will still be larger when Canopy scales up to 2200 acres. On another note, the news cycle loves a good story and by partnering with a 1st Nations community, Isol gains some free news time for their company. Free airtime to promote your company brings new eyes and new investors. A smart move which benefits both he company and 1st Nation's communities.

ISODIOL INTERNATIONAL INC. SIGNS PARTNERSHIP AGREEMENT WITH KAWACATOOSE FIRST NATION

Isodiol International Inc. has signed a partnership agreement with Kawacatoose First Nation, a leader and forward-thinking band with operations and land in Saskatchewan.

Isodiol will partner with Kawacatoose in cultivating and manufacturing high-yielding CBD (cannabidiol) derived from industrial hemp as well as exploring additional economic opportunities with Kawacatoose in commercializing the hemp byproduct into finished goods.

Under the terms of this agreement, Kawacatoose will provide up to 3,000 farmable acres of land, as it becomes available and certain conditions are met by both parties, on a cost-plus model. Kawacatoose, with the support of Isodiol, will also assemble a co-operative with neighbouring bands within Saskatchewan, providing province-wide economic benefits.

Marcos Agramont, chief executive officer of Isodiol International, stated: "This is another strong step taken by the company to expand our footprint in Canada. The company will have significant access to the highest quality CBD, as Kawacatoose will provide the labour necessary to maintain and improve the farmland. The company will also provide expert consultation and advice to Kawacatoose and the future co-op on all cultivation methods and standards applicable to the crop to ensure we remain consistent among all of our family of brands."

For more information on Isodiol, please visit the company's website.

About Isodiol International Inc.

Isodiol is the market leader in pharmaceutical-grade phytochemical compounds and the industry leader in the manufacturing and development of CBD (cannabidiol) consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry, including commercialization of 99-per-cent-plus pure, bioactive pharmaceutical-grade cannabinoids, microencapsulations, and nanotechnology for the highest-quality consumable and topical skin care products.

Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and will aggressively continue international expansion into Latin America, Asia and Europe.

We seek Safe Harbor.

© 2018 Canjex Publishing Ltd. All rights reserved.


Bullboard Posts